Abstract The spinal cord is composed of distinct neuronal groups with well-defined anatomic connections. In some transgenic (Tg) models of Alzheimer's disease (AD), amyloid plaques develop in this structure, although the underlying cellular mechanism remains elusive. We attempted to explore the origin, evolution, and modulation of spinal b-amyloid (Ab) deposition using Tg mice harboring five familiar AD-related mutations (5XFAD) as an experiential model. Dystrophic neuritic elements with enhanced b-secretase-1 (BACE1) immunoreactivity (IR) appeared as early as 2 months of age, and increased with age up to 12 months examined in this study, mostly over the ventral horn (VH). Extracellular Ab IR emerged and developed during this same period, site-specifically co-existing with BACE1-labeled neurites often in the vicinity of large VH neurons that expressed the mutant human APP. The BACE1-labeled neurites almost invariably colocalized with b-amyloid precursor protein (APP) and synaptophysin, and frequently with the vesicular glutamate transporter-1 (VGLUT). Reduced IR for the neuronal-specific nuclear antigen (NeuN) occurred in the VH by 12 months of age. In 8-month-old animals surviving 6 months after a unilateral sciatic nerve transection, there were significant increases of Ab, BACE1, and VGLUT IR in the VN of the ipsilateral relative to contralateral lumbar spinal segments. These results suggest that extracellular Ab deposition in 5XFAD mouse spinal cord relates to a progressive and amyloidogenic synaptic pathology largely involving presynaptic axon terminals from projection neurons in the brain. Spinal neuritic plaque formation is enhanced after peripheral axotomy, suggesting a retrograde transneuronal modulation on pathogenesis.
Introduction b-Amyloid (Ab) peptides are produced following b-secretase-1 (BACE1 or BACE) and c-secretase-mediated b-and c-site cleavages of the amyloid precursor protein (APP) (Vassar et al. 2009; Chow et al. 2010) , and are catabolized likely via enzymatic degradation, glial phagocytosis, and vascular clearance (Miners et al. 2011; Thal 2012) . Because of their amphiphilic nature, Ab peptides tend to aggregate into large insoluble forms leading to the formation of extracellular plaques, a hallmark neuropathology in Alzheimer's disease (AD) (Braak et al. 2011; Jucker and Walker 2011) . There exist different hypotheses explaining why and how plaques develop in the brain. The classic amyloid hypothesis posits a rise of free-floating interstitial Ab as the initial step for plaque development, which in familial AD is caused by increased production and in sporadic AD by reduced clearance, of the peptides (http://www.alzforum.org/res/adh/cur/knowntheamyloid cascade.asp). Alterations in Ab composition (e.g., Ab42/ Ab40 ration) or fibrillary property are also considered as factors driving plaque pathogenesis (Chiang et al. 2008; Okereke et al. 2009; Kuperstein et al. 2010; Hata et al. 2011) . The sink hypothesis suggests reduced brain-to-blood efflux, or increased periphery-to-central transportation, of Ab as the cause of cerebral amyloidosis . The prion hypothesis suggests that Ab peptides may undergo a self-propagating conformational change resulting in amyloidosis in a transmissible manner (Frost and Diamond 2010; Polymenidou and Cleveland 2012) . Pharmaceutical strategies aiming at these different amyloidogenic events are being developed for AD treatment and prevention. As many anti-Ab therapies fail to reverse or slow down neurological and cognitive declines in clinical trials, earlier drug administration is considered to be essential, although some call for a better understanding of the amyloid pathogenic process and its role in AD etiology (Pimplikar 2009; Struble et al. 2010; D'Alton and George, 2011; Panza et al. 2011; No authors listed 2011) .
As the initiating and rate-limiting enzyme for Ab genesis, BACE1 may serve an ideal marker to elucidate plaque pathogenesis. BACE1, especially its upregulation if occurs, would provide biochemical and anatomic clues for in situ Ab overproduction and potentially plaque formation. Accordingly, we studied plaque pathogenesis by correlating BACE1 to Ab and neuronal/synaptic changes in transgenic (Tg) AD mouse and primate brains (Zhang et al. 2009 Cai et al. 2010 Cai et al. , 2012a . BACE1 elevation appears to be anatomically linked to synaptic/axonal terminal pathogenesis as well as local Ab deposition in the brain. As neuronal organization and connectivity are rather complex in a given brain region, it is somewhat difficult to identify particular cellular/pathway-based factors that might modulate cerebral plaque development.
The spinal cord is a part of the central nervous system with its neuronal organization and connectivity well-established anatomically. Amyloid plaques can be found in the spinal cord in AD patients (Bugiani et al. 1989; Ogomori et al. 1989) . Recent studies also report the presence of amyloid plaques in the spinal cord of Tg mice expressing familial AD (FAD)-related APP and presenilins, including the Tg2576, 2XFAD, and 5XFAD strains (Wirths et al. 2006; Seo et al. 2010; Jawhar et al. 2012) . In this study, we explored plaque pathogenesis in the spinal cord of 5XFAD mice. Age-related spinal amyloidogenesis occurred in association with a presynaptic axon terminal pathology involving largely the descending glutamatergic projection systems, which could be enhanced after a traumatic injury to motoneurons axons.
Materials and Methods

Animals and Surgery
Animal use in this study was in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals. All experimental procedures were approved by the Animal Care and Use Committee of Southern Illinois University at Carbondale and the Ethics Committee for Animal Use at Central South University. A small colony of 5XFAD [B6SJL-Tg (APPSwFlLon, PSEN1*M146L*L286V) 6799Vas/J] mice was established using breeders from the Jackson Laboratory (Bar Harbor, ME) (Oakley et al. 2006) . For analysis of age-related plaque development, male Tg animals were examined at 1-2, 4, 8, and12 months of age (n = 4-6 per age point). Male C57BL/6J mice at matched age points (n = 4 per age group) were used as controls (for the lack of AD-like pathology) (Zhang et al. 2009 ). Twelve 2-month-old male Tg were used for study of the effect of unilateral peripheral nerve injury. For surgery, the animals were anesthetized with sodium pentobarbital (50 mg/kg, i.p.). The left hind limb was shaved and swabbed with an antiseptic solution (Betadine). A longitudinal skin incision was made around the back of the upper thigh, and the hamstring and gluteal muscles were bluntly separated to expose the sciatic nerve. The nerve was transected, with approximately 2-mm nerve segment removed. The muscles and skin were sutured. Animals were allowed to survive until 4 (n = 2), 6 (n = 4), and 8 (n = 4) months of age (two other operated animals died accidently).
Tissue Preparation
Mice were deeply anesthetized with sodium pentobarbital (100 mg/kg, i.p.) and perfused with 4 % paraformaldehyde in 0.1 M phosphate buffer. The spinal cord together with the left dorsal root ganglias (DRGs, for orientation purpose) was dissected out, post-fixed in the perfusion fixative overnight, and cryoprotected in 30 % sucrose at 4°C until tissue sank. Cross sections of the lumber spinal segments (L1-5) were processed and analyzed in this study. Twelve sets of 30-lm thick sections were collected in order in 0.01 M phosphate-buffered saline (PBS, pH 7.4) in cell culture plates. Additional six sets of 12-lm and six sets of 6-lm thick sections were collected by thaw-mounting on positively charged microslides. Accordingly, each set consisted of equally spaced sections at *500-lm intervals.
Immunohistochemistry
Sets of the 30-lm sections from each animal were used for Nissl stain, immunohistochemistry (including BACE1, Ab antibodies 6E10, 12F4, Ter42, NeuN, see Table 1 ) with the avidin-biotin complex (ABC) method and histochemistry for nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-d). For BACE1 labeling, sections were first treated in 50 % formamide and 50 % 2XSSC (300 mM sodium chloride, 30 mM sodium citrate) at 65°C for 60 (30-lm sections) and 20 min (6-lm sections) (Zhang et al. 2009 ). For Ab antibody immunohistochemistry, sections were pretreated with 50 % formic acid at room temperature followed by several washes with 0.05 M Tris-HCl buffer (pH 8.5). After antigen retrieval, sections were preincubated in 1 % H 2 O 2 in PBS for 30 min and in 5 % horse serum in PBS with 0.3 % Triton X-100 for 1 h. Sections were then reacted with a primary antibody at preoptimized concentration overnight at 4°C. Sections were further reacted with a biotinylated universal secondary antibody (horse anti-goat, rabbit and mouse IgGs) at 1:400 for 2 h, and subsequently with the ABC reagents (1:400) (Vector Laboratories, Burlingame, CA) for another hour, at room temperature. Immunoreaction product was visualized in 0.003 % H 2 O 2 , 0.05 % 3,3-diaminobenzidine (DAB). Three 10-min washes with PBS were used between incubations. After staining, the sections were allowed to air-dry, cleared, and coverslippered. Double immunofluorescence was carried out by a pretreatment of thaw-mount sections in PBS containing 5 % donkey serum to lower non-specific binding. Then the sections were incubated with a pair of primary antibodies raised in different species (rabbit, mouse, or goat) overnight at room temperature. This was followed by a 2 h reaction with Alexa Fluor Ò 488 and Alexa Fluor Ò 594 conjugated donkey anti-mouse, rabbit, or goat IgGs (1:400, Invitrogen, Carlsbad, CA). Sections were then counterstained with Bisbenzimide (Hoechst 33342, 1:50000), washed, and mounted with anti-fading medium before microscopic examination.
The BACE1 antibody used in this study was raised in rabbit against a synthetic peptide corresponding to aminoacid residues 46-163 of human BACE1. It detects a 70-kDa band in brain homogenates by western blot, which is absent in BACE1 knockout tissue (Laird et al. 2005; Xiong et al. 2007 ). This antibody does not visualize any specific reactivity in BACE1 knockout mouse brain and spinal cord (Zhang et al. 2009 ). Other primary antibodies were commesurized, with their specificity initially tested by preabsorption of the primary antibody with a neutralizing antigen peptide and omission of the primary antibody in the immunolabeling protocol. Neither condition yielded specific immunolabeling in brain sections. In each batch of peroxidase or immunofluorescent stain, several spine cord sections were processed along with the experimental sections, excluding the exposure to the primary antibody. These latter sections were used to define the levels of background reactivity in densitometric analysis.
NADPH-d Histochemistry
Sections were incubated in 0.05 M Tris-HCl buffered saline (pH 8.0, TBS) containing 0.3 % Triton X-100, 1 mM b-NADPH-d (N7505, Sigma-Aldrich), 0.8 mM nitroblue tetrazolium (NBT, N6639, Sigma-Aldrich), and 5 % dimethyl sulfoxide at 37°C for 1 h. Selected sections were further immunostained for BACE1 using the DABperoxidase method to assess colocalization.
Imaging, Quantitative Analysis and Figure Preparation
All sections were examined on Olympus (BX60 and BX53) fluorescent microscopes equipped with image analysis systems (Optronics, Goleta, CA; CellSens Standard, Olympus, Japan). Images were captured with 29 to 409 objective lens. Optic density of immunoreactivity (IR) over the spinal gray matter was obtained using the OptiQuant analysis software (Parkard Instruments, Meriden, CT). Specific labeling densities (expressed as digital light units per squire mm, DLU/mm 2 ) in area of interest in Tg spinal cord was calculated by subtracting either the background (obtained 
Results
Overall BACE1 Expression Pattern in Non-Tg and 5XFAD Mouse Spinal Cord
In non-Tg spinal cord, BACE1 IR was present over the gray matter, with little labeling in the white matter ( Fig. 1a) , consistent with the pattern shown in a previous report using a different antibody . The labeling was generally diffuse or neuropil-like across the ventral horn (VH), intermediate zone (IZ), and dorsal horn (DH). Lamina I and II of the DH exhibited a noticeably higher density than the remaining gray matter areas (Fig. 1a, c) . Faintly labeled perikaryal profiles were identifiable at high magnification, especially in the VH. These profiles were relatively large in size, therefore would likely represent the ventral motoneurons (Fig. 1b) . No apparent cellular profiles were seen in the IZ and DH (Fig. 1c) . It should be noted that fairly distinct perikaryal BACE IR existed in the DRG ( Fig. 1d-i ). These labeled somata were considerably large and resembled the primary sensory neurons. In 5XFAD mouse spinal cord, heavily labeled BACE1 immunoreactive profiles occurred in the gray matter (Fig. 1j ). These profiles existed as isolated spheroids or swollen processes, as well as rosette-like clusters of neurites in varying size. They showed age-related changes and were identified as dystrophic axonal neurites sitespecifically associated with plaque development (Fig. 1m-o ), which will be detailed in following sections. As with the nonTg mice, BACE1-labeled somata were found in the DRG in 5XFAD mice. However, there were no apparent age and genotype-related alteration regarding this perikaryal BACE1 IR (Fig. 1j, p-r) . Also similar to non-Tg, faint BACE1 IR was seen in some VH neurons in 5XFAD mice (e.g., Figs. 1m, 2a), which exhibited little age-related changes by microscopic examination.
Expression of Tg APP in 5XFAD Mouse Spinal Cord
The monoclonal Ab antibody 6E10 was used to assess the cellular expression of putative mutant human APP in 5XFAD spinal cord, using non-Tg tissue as assay control (Winton et al. 2011 ). In non-Tg spinal cord at any age, no 6E10 IR was found in the gray or white matter of the spinal cord (Fig. 1e, f) . However, there was 6E10 IR in the DRG that appeared in dorsal root fiber bundles and around BACE1-labeled somata (likely non-specific reactivity). The BACE1-labeled DRG somata per se did not exhibit apparent 6E10 IR (Fig. 1h, i) . In 5XFAD spinal cord, 6E10 IR occurred in neuronal somata over the gray matter in preplaque young animals (as early as 1 month old, not shown) as well as older ones with spinal amyloid pathology. Shown as an example (Fig. 1j-o) , 6E10 IR was present in neuronal somata and proximal dendrites, in addition to extracellular Ab deposits, in the spinal cord from 8-monthold Tg. The labeled neurons varied in size and were distributed largely in the VN (Fig. 1k, n) . It should be noted that 6E10 IR also colocalized with BACE1 IR in dystrophic neurites ( Fig. 1m-o, arrows) . Moving from small/isolated BACE1/6E10-labeled neuritic spheroids to large neuritic clusters (arrows), there was a trend of appearance and buildup of local extracellular Ab deposits (arrowheads) seen in double labeling preparation ( Fig. 1m-o; follow the profiles marked with 1 ? 2 ? 3 ? 4 ? 5 in o). Different from the pattern seen in non-Tg samples, 6E10 IR occurred in the somata of DRG neurons, colocalizing with BACE1 IR (Fig. 1p-r) .
Age-Related Increase of BACE1 and Extracellular Ab IR in 5XFAD Mouse Spinal Cord A small amount of discretely distributed BACE immunoreactive neuritic elements were identifiable in the VH in 5XFAD mice as early as 2 months of age (data not shown). These neurites were clearly present in the VH, IZ, and deep DH in 4 month-old Tg (Fig. 2a-c) . A small amount of extracellular Ab deposits also occurred at this age regionally corresponded with the BACE1-labeled neurites (Fig. 2b) , as visualized with the 12F4 antibody that labels extracellular Ab but rarely neuronal somata . The amount of BACE1-labeled neurites and Ab deposits were increased at 8 months, and further at 12 months, of age in the VH, IZ, and deep DH (Fig. 2d-h ). BACE1-labeled neurites and Ab deposits were absent in lamina I and II at all ages examined (Fig. 2) . Neither BACE1-labeled neuritic profile nor extracellular Ab deposits were detectable in the spinal cord in double immunofluorescent preparation in non-Tg mice at all age time points examined (Figs. 1a-c, 2j-l). Fig. 1 Characterization of overall BACE1 alteration and Tg human APP expression in 5XFAD relative to non-Tg spinal cord and DRG with the peroxidase-DAB method (a-c) and immunofluorescent. Bisbenzimide (blue) nuclear counterstain is shown in same imagines for histological orientation (d-r). BACE1 IR in non-Tg spinal cord shows largely a neuropil-like pattern restricted to the gray matter, with lamina I and II of the DH exhibited a heavier IR (a-d). Faintly stained perikarya are seen in the VH (arrows, b). BACE1-labeled somata are present in the DRG (d, g). 6E10 IR is absent in the spinal cord, although putative non-specific IR occurs in the DRG in fiber bundles and likely satellite glia (e, h, i). In Tg spinal cord, distinct profiles are labeled by BACE1 and 6E10 antibodies (j-l). At high magnification, BACE1-labeled elements are swollen and sprouting neurites and clusters arranged in rosette-like configuration (m). 6E10 IR not only colocalizes in some of these neurites (m-o, arrows) but also occurs in neuronal perikarya, and appears as extracellular fibrillary elements (arrowheads) with a spreading configuration (n, o). There appears to be a trend of emergence and buildup of the extracellular deposits from small-to large-sized dystrophic neuritic clusters (follow the profiles marked with 1-5 in o). The amyloid deposits occur commonly around the central zone of the neuritic cluster but may spread to the periphery. cc central cannel. 6E10 IR exists in DRG neuronal somata colocalizing with BACE1 in Tg materials (p-r). Scale bar 0.5 mm (a) applying to (d-f, j-l); equivalent to 50 lm for remaining panels (Color figure online) Neurotox Res (2013) 24:1-14 5
A correlated densitometry was carried out in the Tg to determine the trend of changes in BACE1 relative to extracellular Ab deposits with age. Four equally spaced (500 lm) lumber spinal sections in each animal were used for quantification (n = 4 per age point). The densities of BACE1 and 12F4 IR were measured correlatively over the VH, IZ, and deep DH with a threshold selection approach, with the area of interest defined by selecting the region with plaques as the measuring template for both BACE1 and 12F4 IR (Fig. 2a, b) . The optic densities over the same area in batch-processed non-Tg spinal cord were used as cutoff levels to calculate ''specific'' or elevated BACE1 and 12F4 IR in the Tg. A progressive increase in specific BACE1 (P \ 0.0001, F = 34.3, df = 3, 12) and 12F4 (P \ 0.0001, F = 122.7, df = 3, 12) IR occurred from 4 to 8, and to 12 months of age in the Tg (Fig. 1i) . Different from that seen in 4 and 8 month-old animals, the relative density of 12F4 IR became higher than that of the BACE1 IR at 12 months of age (Fig. 1i ).
Cellular Localization of BACE1/Ab Antibody IR in 5XFAD Mouse Spinal Cord
Previously we showed a differential Ab antibody labeling at axon terminals expressing increased BACE1 in the forebrain in several Tg AD models (Zhang et al. 2009; Cai et al. 2012a, b) . This phenomenon was also found in the spinal cord of 5XFAD mice. Thus, in addition to 6E10 (Fig. 1m-o) , BACE1 IR co-localized with 4G8 ( Fig. 3a-c) or 3D6 (Fig. 3d-f ) IR in swollen/sprouting neurites. Of note, this intra-axonal Ab antibody labeling was generally weaker relative to extracellular Ab fibrils. Also, small/isolated BACE1 immunoreactive spheroids were often not associated with local extracellular Ab IR, whereas large spheroids, especially rosette-like neuritic clusters, were generally surrounded by Ab deposits (Figs. 1o, 3c, f) . In the latter case, the Ab deposits concentrated at the center, but could spread across and beyond the periphery, of a given neuritic cluster ( Figs. 1m-o; 3a-f) . The neuritic spheroids and clusters were also distinctly labeled by the 22C11 antibody (Fig. 3g, i) .
A close spatial relationship between neuritic plaques and large VH neurons was noticeable in the spinal cord. Thus, in BACE1/6E10 or BACE1/4G8 double-labeled sections (note: 3D6 IR is absent in neuronal somata), the neuritic plaques (dystrophic neurites and extracellular Ab) were commonly present in proximity of the somata or primary dendrites of large multipolar neurons in the VH (Figs. 1o, 3c, f) . Similarly, neuritic clusters coexpressing BACE1/APP occurred in the vicinity of large VH neurons (Fig. 3i) . Notably, APP expression in neuronal somata juxtaposed to neuritic plaques appeared to be reduced relative to those distributed apart from neuritic plaques (Fig. 3g-i , comparing somata labeled with 1-3).
BACE1-labeled swollen/sprouting neurites in 5XFAD mouse spinal cord colocalized with synaptophysin ( Fig. 3j-l) . Among specific neuronal phenotype markers, BACE1 immunoreactive neurites mostly co-expressed VGLUT-1 (VGLUT1, Fig. 3m, p) . There was infrequent colocalization of BACE with choline acetyltransferase (ChAT) (Fig. 4a-c) , GAD67 (Fig. 4d, f) , calbindin ( Fig. 4g-i) , NADPH-d (Fig. 4j-l) , and PV (not shown). No colocalization was found between BACE1 and MAP2 (not shown) or BACE and glial fibrillary acidic protein (GFAP) (Fig. 4m-o) .
Age-Related Neuronal Loss in 5XFAD Mouse Spinal Cord
Neuronal degeneration has been reported in the brain in 5XFAD mice (Oakley et al. 2006; Ohno et al. 2007; Jawhar et al. 2012) . We assessed the timing and extent of neuronal loss in 5XFAD mouse spinal cord, in relative to neuritic and amyloid pathology, using a systematic approach. The analyses were conducted in 4 equally spaced (500 lm apart) lumber spinal sections doublelabeled for BACE1 with NeuN and BACE1 with 12F4 (bisbenzimide counterstained). C57BL/6J mice were used as control for neuronal count. NeuN immunoreactive perikarya containing clearly present nuclei were countered manually in the ventral left or right quadrant (largely corresponding to the VN, including a small portion of IZ) of the spinal gray matter in reference to the central cannel (cc), in Tg and non-Tg mice at 2, 4, 8, and 12 months of age. ''Percent area occupied by labeled elements'' was also used for comparative analysis of NeuN, BACE1, and Ab IR in 5XFAD mice at 8 and 12 months age points (Fig. 5a-l) .
Compared to non-Tg counterparts, numeric density of neurons in VH was comparable between 5XFAD and non-Tg mice at 2 (333.5 ± 38.9 vs. 344.5 ± 29.2) and 4 (317.4 ± 55.7 vs. 330.7 ± 38.9) months of age (Fig. 5m) , but tended to reduce in the former afterward. Thus, the density reduced in 5XFAD relative to controls with a marginal statistical significance at 8 months (302.9 ± 35.7 vs. 331.7 ± 37.3, P = 0.055), but significantly at 12 months (262.4 ± 41.6 vs. 327.4 ± 25.5, P = 0.012), of age (Fig. 5m) . The percent area occupied by NeuN immunoreactive elements (including perikarya that passing or not passing the cell nuclei) reduced in 5XFAD relative to controls at 12 months of age (6.54 ± 0.32 vs. 7.05 ± 0.14 %, P = 0.030), but not at 8 months (6.97 ± 0.35 vs. 7.05 ± 0.14 %, P = 0.356; Fig. 5n, o) . The percent area occupied by BACE1-labeled neurites increased at 12 (6.83 ± 0.48 %) relative to 8 (3.58 ± 0.52 %) months of age in the Tg (P \ 0.001; Fig. 5o ). The percent area occupied by extracellular Ab IR increased at 12 (10.83 ± 0.89 %) relative to 8 (4.28 ± 0.73 %) months in the Tg (P \ 0.0001; Fig. 5o ).
Increased Plaque Formation After Peripheral Nerve Injury in 5XFAD Mouse Spinal Cord
Experimental effects were examined in 4-8-month-old Tg after unilateral sciatic nerve transection at 2 months, considering the intense neuropathology at 12 months of age (see Fig. 2 ) that might cause a ceiling effect. In two animals examined after surviving 2 months post-axotomy, there was no microscopically impressive difference in immunolabelings between the ipsilateral and contralateral gray matter (therefore not included in analysis). Quantification was thus carried out to determine axotomy-induced changes at 4 and 6 months post-axotomy (Fig. 6) . Specific density of labeling in area of interest was calculated by subtracting background from total optic density readings, with the former obtained from batch-processed sections excluding exposure to primary antibody. For statistical comparison, data were normalized to the mean density (defined as 100 %) obtained from the contralateral VH in the 6-month-old group, correspondingly for each type of immunolabeling.
Specific density of extracellular Ab deposits (12F4 IR) was higher in the ipsilateral (135.9 ± 13.5 %, mean ± SD, same format below) than contralateral (100 ± 11.5 %) VH in the 6-month-old group (P = 0.076, paired Student's t test, same test below), more prominent in the 8-month-old group (265. 6.9 ± 14.9 vs. 146.3 ± 19.6 %; P = 0.008) (Fig. 6a-c) . Specific density of BACE1-labeled dystrophic neurites increased in the ipsilateral (121.8 ± 9.7 %) relative to contralateral (100 ± 10.3 %) VH at 6 months (P = 0.095), and 8 months (201.2 ± 14.8 % vs. 138.7 ± 11.1 %; P = 0.030) (Fig. 6d-f) . A trend of increase in VGLUT-specific density in ipsilateral (117.7 ± 11.2 %) relative to contralateral i The specific densities measured over the area defined in (a, b), as a function of age. There exists an age-dependent increased of BACE1 and 12F4 reactivities, as indicated by ANOVA analysis. Note that the mean density of amyloid deposit exceeds that of BACE1 after but not before 8 months of age. j-l The levels of BACE1 and 12F4 reactivities in a batch-processed section from a non-Tg spinal cord, as an example for defining the cutoff threshold for calculating the ''specific densities'' in Tg tissue. Bisbenzimide nuclear stain is included for histological orientation (c, f, l). Abbreviations are as defined in Fig. 1 . Scale bar 0.5 mm (a) applying to all image panels Neurotox Res (2013) 24:1-14 7 (100 ± 9.0 %) sides was detected at 6 months (P = 0.153), and was significant at 8 months of age (188.6 ± 8.5 % vs. 129.5 ± 9.7 %; P = 0.020) (Fig. 6g-i) . No difference was detected for the specific NeuN IR density between the ipsilateral and contralateral sides at 6 (96.0 ± 9.3 vs. 100 ± 8.4 %; P = 0.730) or 8 (102.2 ± 13.7 vs. 97.4 ± 7.4 %; P = 0.643) months of age ( Fig. 6j-l) .
Discussion
Spinal Ab Deposition Largely Correlates with Glutamatergic Axonopathy in 5XFAD Mice
The major origin of plaque-associated Ab remains a subject of ongoing research, while a variety of sources have Unlike 6E10 (see Fig. 1n , o) and 4G8 (b, c), 3D6 does not label perikaryal profiles. g-i Colocalization of BACE1 and b-amyloid precursor protein (APP) detected by 22C11 in dystrophic neurites. The neuritic clusters or neuritic plaques (arrows) are often juxtaposed to the somata (asterisks, a-c, g-i) or dendrites (i, paired purple arrows) of large VH neurons. Frequent colocalization of BACE1 with synaptophysin (j-l) and VGLUT1 (m-p) in swollen/sprouting axon terminals. Abbreviations are the same as defined in Fig. 1 . Scale bar 50 lm (a) applying to all panels (Color figure online) been proposed (Fiala 2007) . For instance, it is suggested that peripheral Ab may contribute to central plaque formation. This would require active transportation of plasma Ab across brain-blood barrier against a steep concentration gradient (from pg/ml levels in blood to ng/ml levels in brain or CSF) (Deane et al. 2009; Seppälä et al. 2011; Figurski et al. 2012) . Notably, Ab plaques are rarely reported in the periphery, whereas many other b-sheet proteins can aggregate to form amyloidosis in bodily tissues/organs (Merlini et al. 2011) . Glial cells are suggested to produce Ab and perhaps contribute to plaque formation (Zhao et al. 2011 ). However, these cells are also considered as the principal machinery for Ab clearance (Thal 2012) . Intracellular Ab released from neuronal somata and dendrites could lead to extracellular Ab accumulation and plaque formation. However, studies indicate that some prominent Ab antibody labeling in neuronal somata has a poor value in predicting regional cerebral plaque formation over time in human or Tg mouse brain (Wegiel et al. 2007; Aho et al. 2010; Winton et al. 2011; Cai et al. 2012a) .
In this study, we observe increased BACE1 IR in the spinal cord of 5XFAD mice as early as 2 months of age, distributed mostly over the VH. The density or occupying area of BACE1-labeled profiles increase with age until at least 1 year old. These profiles are individually surrounded by, but not precisely overlap with, extracellular Ab deposits. Correlative densitometry shows a parallel Fig. 5 Images, quantification methodology, and histograms demonstrating age-related loss of neurons in the VH of 5XFAD mice relative non-Tg counterparts. Measurements were carried out in a ventral quadrant of the gray matter in reference to the cc. The ventrolateral border of measuring area corresponds to that of the VH (as outlined in purple in b, h). Cell count was carried out in this area in Tg and controls at 2, 4, 8, and 12 months of age (n = 3), with perikarya exhibiting immunoreactivity for neuron-specific nuclear antigen (NeuN) but also containing bisbenzimide positive nuclei recorded (m). Correlative analysis of area occupied by NeuN, BACE, and 12F4 Ab (images not shown) immunoreactivity was conducted in 8-and 12 month-old Tg using a threshold-selection approach; the cutoff level was obtained from batch-processed sections not exposed to primary antibodies (n, o). A reduced density of NeuN positive profiles is noticeable in images from a 12-month-old Tg (b, e) relative to age-matched control (h, k). Numerical density of NeuN positive neurons is reduced in 5XFAD mice at 8 and 12 months of age relative to controls (m). Area occupied by all NeuN positive elements is reduced in 12-month-old Tg relative to control (o). Area occupied by BACE1 and 12F4 positive profiles is increased significantly in the Tg from 8 to 12 months of age (o). DH dorsal horn. Scale bar 250 lm in (a) applying to (b, c, g-i) , equal to 50 lm for (d-f, j-l) (Color figure online) increase in the amount of BACE1-labeled elements and Ab deposits with age. The density of extracellular Ab IR tends to exceed that of BACE1 IR after 8 months of age, likely representing a time-dependent accumulative effect of the insoluble Ab deposits. The BACE1-labeled elements also exhibit 22C11 and 6E10 IR, suggesting an overexpression of the Tg human APP or perhaps murine APP as well. These profiles are further identified to be swollen/sprouting, or dystrophic, axon terminals that are predominantly glutamatergic and often occur around the somata of VH neurons. A small fraction of the BACE1-labeled terminals colocalize with GABAergic and cholinergic markers (e.g., Fig. 6 Increased amyloid and neuritic pathology in 5XFAD mouse spinal cord following sciatic nerve transection. The left panels show images from an 8-month-old Tg surviving 6 months after unilateral sciatic nerve cut. The middle panels show threshold-based selection of labeled profiles. Specific optic density was calculated with a cutoff set at the level of non-specific reactivity measured in sections processed in the absence of primary antibody. Area of interest includes the ventral quadrants relative to cc, as marked by yellow broken lines in the left panels. Histograms show relative mean specific densities normalized to the mean (defined as 100 %, green lines in histograms) from the contralateral VH in 6-month-old Tg. The densities of Ab (a-c), BACE1 (d-f), and VGLUT1 (g-i) IR are significantly higher in the ipsilateral (ipsi.) than contralateral (contra.) VH in 8-month-old Tg (with difference of Ab density approaching significance in the 6-month-old group). No difference exists for NeuN density between the two sides in 6-and 8-month-old animals (j-l). Scale bars (0.5 mm) in (a) and (b) apply to the same vertical panels of images, respectively (Color figure online) Neurotox Res (2013) 24:1-14 11 GAD, CB, NADPH-d, ChAT), therefore, may derive from spinal interneurons and motoneurons (i.e., their axonal collaterals) (Xie et al. 2003; Brownstone and Bui 2010) . In contrast to dystrophic axonal neurites, neuronal somata and dendrites in Tg spinal cord exhibit minimal BACE1 IR, or change in labeling intensity, relative to non-Tg counterparts. Spinal cord white matter exhibits little BACE1 IR in non-Tg and 5XFAD mice. Interestingly, the somata and likely central terminals (i.e., in lamina I and II) of DRG neurons exhibit fairly strong constitutive BACE1 expression in both genotypes. Yet, no or minimal extracellular Ab IR occurs in the DRG or lamina I and II in the Tg, despite an expression of the putative Tg APP (6E10 IR) in the DRG neurons. Taken these findings together, it appears that plaque-forming Ab products in 5XFAD mouse spinal cord may largely derive from dystrophic presynaptic axon terminals originated from glutamatergic neurons in the brain, which may include projection neurons in the motor cortex and perhaps some subcortical structures that innervate the spinal cord neurons.
As with a report in Tg 2576 mice (Seo et al. 2010) , an age-related loss of neuronal somata is detectable in the VH in 5XFAD mice relative to non-Tg controls. Thus, the numerical density or occupying area of NeuN immunoreactive somata tends to decline at 8 months of age, and is significantly reduced at 12 months. In addition, a reduction in APP expression is noticeable in neuronal perikarya apposing to, relative to those apart from, neuritic plaques. Thus, established amyloid plaques may affect the viability of nearby neurons but likely cause neuronal death at a certain stage. Because neuritic plaques begin to develop long before neuronal loss, it appears unlikely that spinal plaque formation is initially seeded by Ab products released from dying or dead neurons (Fiala 2007 ).
Motoneuron Axotomy Promotes Spinal Neuritic Plaque Pathogenesis in 5XFAD Mice
The perisomatic distribution of neuritic plaques and the predominant glutamatergic identity of dystrophic neurites appear to suggest a certain synaptic mechanism involved in plaque development in the spinal cord. Previous studies show that peripheral nerve injury causes synaptic reorganization on the somata and dendrites of motoneurons in the spinal cord as well as neurons in higher brain centers (Sanes et al. 1990; Brumovsky et al. 2007; Navarro et al. 2007; Zelano et al. 2009; Alvarez et al. 2011 ). We, therefore, explored whether sciatic nerve axotomy may influence neuritic and amyloid plaque pathogenesis in the VH of the lumber spinal cord.
The amounts of extracellular Ab deposits, BACE1-and VGLUT1-labeled dystrophic neurites tend to increase in the ipsilateral relative to contralateral lumbar VH in 6-month-old Tg 4 months after unilateral sciatic nerve transection. These changes become statistically significant by 6 months after axotomy. In contrast, no differences are found between the ipsilateral and contralateral VH in the amount of NeuN IR in 6-and 8 month-old Tg following axotomy. The enhanced neuritic (BACE1 and VGLUT1 labeled) and amyloid pathogenesis might occur as a reactive response in the presynaptic axon terminals on the somata and dendrites of the motoneurons subjected to axotomy (Brännström et al. 1992; Rose and Odlozinski 1998) . It is possible that the transgene expression (e.g., 6E10 IR) in pre-and/or post-synaptic components might somehow promote a dystrophic and amyloidogenic response in some central excitatory axonal terminals innervating spinal motoneurons after these neurons are traumatized. The lack of neuron loss in the VH is consistent with previous reports showing well survival of spinal motoneurons after axotomy in adult rodents (Vanden Noven et al. 2003; Xu et al. 2010) .
It should be noted that a previous study shows APP and Ab antibody-labeled neurites in the VH of aged rat spinal cord, which is increased after periphery axotomy, in the absence of motoneuron degeneration (Xie et al. 2003) . In this study, we observe labeling of dystrophic neurites by 6E10, 3D6, and 4G8 in the spinal cord. Early onset intraaxonal Ab antibody labeling also occurs in the cerebral cortex and hippocampus in several Tg AD models, which is associated with or followed by local extracellular amyloidosis (Zhang et al. 2009; Cai et al. 2012a ). However, in the olfactory bulb glomeruli, axonal terminal Ab antibody labeling persists in the absence of local extracellular amyloidosis (Cai et al. 2012b) . We have hypothesized that this type of intra-axonal/synaptic labeling might relate to a cross-reactivity of some Ab antibodies to the APP b-site cleavage fragment, b-CTF (in addition to APP), although we do not rule out a possibility that the labeling represents true intraneuronal Ab (Cai et al. 2012a, b) . In comparison, the lack of extracellular Ab deposition in aged rat spinal cord could be because normal rodents do not produce a sufficient amount of the most fibrillary Ab42 species (Xie et al. 2003) . Alternatively, BACE1 upregulation might be not prominent in spinal neurites in aged rats following axotomy, thus rendering a low vulnerability of amyloidosis in wild-type rodent.
In summary, this study identifies early and progressive presynaptic terminal pathology involving predominantly the glutamatergic phenotype in the spinal cord of 5XFAD mice, which is associated with BACE1 and potentially APP b-CTF elevations as well as local extracellular Ab deposition. Sciatic nerve axotomy promotes the axon terminal pathology but also plaque pathogenesis in lumber spinal cord. Together with previous findings in the brain (Zhang et al. 2009 Cai et al. 2010 Cai et al. , 2012a Yan et al. 2012) , the data point to a common mechanism for neuritic plaque development in the central nervous system, which is compatible with an increasing notion that AD is a synaptic disease tightly associated with amyloidogenesis within neuronal elements (Palop et al. 2007; Goto et al. 2008; Marcello et al. 2012; Spires-Jones and Knafo 2012) . If the elevated BACE1, its immediate (i.e., b-CTF) or end (Ab) products play a harmful role to synapses (Saganich et al. 2006; Tamayev et al. 2012) , pharmacological inhibition of excessive BACE1 would be an ideal early therapeutic option to prevent synaptic pathogenesis but block amyloid plaque formation in AD (Vassar et al. 2009 ).
